REMIX

Serial Number 88639146
606

Registration Progress

Application Filed
Oct 2, 2019
Under Examination
Oct 13, 2020
Approved for Publication
Aug 18, 2020
Published for Opposition
Aug 18, 2020
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: REMIX
Previous Owner: Remix Therapeutics Inc.
Classes: 005, 042

Trademark Image

REMIX

Basic Information

Serial Number
88639146
Filing Date
October 2, 2019
Published for Opposition
August 18, 2020
Abandonment Date
November 13, 2023
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Nov 13, 2023
Classes
005 042

Rights Holder

Remix Therapeutics Inc.

03
Address
400 Technology Square
Cambridge, MA 02139

Ownership History

Remix Therapeutics Inc.

Original Applicant
03
Cambridge, MA

Remix Therapeutics Inc.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
Christina M. Licursi, Esq.

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

36 events
Date Code Type Description Documents
Nov 13, 2023 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Nov 13, 2023 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Apr 18, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 17, 2023 EX5G S SOU EXTENSION 5 GRANTED Loading...
Apr 12, 2023 EXT5 S SOU EXTENSION 5 FILED Loading...
Apr 17, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 12, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 27, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 25, 2022 EX4G S SOU EXTENSION 4 GRANTED Loading...
Apr 25, 2022 EXT4 S SOU EXTENSION 4 FILED Loading...
Apr 25, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 15, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 13, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Apr 13, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Apr 13, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 15, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 13, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 13, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Oct 13, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 10, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 8, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 8, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 8, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 13, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 18, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 18, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 29, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 16, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 23, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 23, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 23, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 7, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 7, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 7, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 7, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 5, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical and therapeutic preparations for the treatment of cancer, immune system related diseases and disorders, cardiovascular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders
Class 042
pharmaceutical, medical, scientific, and biopharmaceutical research and development

Classification

International Classes
005 042